It is well established that FBC can be classified into molecular subtypes based on gene expression, with BRCA1-mutated tumors showing a prevalence in the basal-like subtype, while BRCA2-mutated FBC may show gene expression patterns that resemble those found in luminal epithelial cells [205,206,207]. The gene discussed is BRCA1; the disease is complete blood cell count.